ATS 2024 Final Program

Click on the session title to view the speakers

207

MONDAY • MAY 20

3:27 circALMS1 Alleviates Pulmonary Microvascular Endothelial Cells Dysfunction in Pulmonary Hypertension 3:39 Chemo-ablation of Cardiopulmonary Afferents by Intrathecal Resiniferatoxin Prevents Pulmonary Hypertension and Right Ventricular Failure by Decreasing NOS1-mediated Neuroinflammation in Thoracic Spinal Cord 3:51 Loss of ROR2 Tyrosine Kinase Receptor Is Associated With Dysfunctional Angiogenesis in PAH Via Inappropriate Focal Adhesion Activation and Disruption of the Endothelial Barrier 4:03 TBX4 Loss-of-function Within the Developing Lung

3:27 Gut-lung Axis: Is Gut Dysgenesis a Risk Factor for Bacterial Pneumonia in Inflammatory Bowel Disease? 3:39 Neutrophil Percentages in Bal Fluid: Implications for Diagnosing Bacterial Pneumonia in Patients With Immunocompromise and Neutropenia 3:51 Longitudinal Importance of the Soluble Receptor for Advanced Glycation End-products in COVID-19 Pneumonia Featured Speaker Presentation: 4:03 Breaking Through: The Latest Advances in Pneumonia Care

Disrupts Postnatal Lung Development and Predisposes to Pulmonary Hypertension

BEHAVIORAL • CLINICAL MINI SYMPOSIUM

BASIC • CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

B97 ADVANCED INSIGHTS INTO

PULMONARY REHABILITATION

2:15 p.m. - 4:15 p.m.

San Diego Convention Center Room 8 (Upper Level)

B96 WHAT IS NEW IN PNEUMONIA? 2:15 p.m. - 4:15 p.m.

Marriott Marquis San Diego Marina Pacific Ballroom 21-22 (Ground Floor, North Tower)

Oral Presentations: 2:15 Association of Duration and Intensity of Physical Activity on Muscle Oxidative Capacity in Older Adults With or Without COPD 2:27 Application of a Theoretical Model to Support Home-based Pulmonary Rehabilitation With Health Coaching and Chronic Obstructive Pulmonary Disease Outcomes 2:39 Exercise Physiology and Biomarkers of Inflammation and Vascular Remodeling in Individuals With Persistent Dyspnea, Fatigue and Exercise Intolerance After COVID-19 2:51 One-minute Sit-To-Stand Test in Fibrotic Interstitial Lung Disease: Correlation With Six-minute Walk Test and PFT 3:03 What Do Pulmonary Rehabilitation Participants Want Their Educational Sessions to Comprise Of? Exploring a Participant-centered Approach to Designing Pulmonary Rehabilitation Education 3:15 Improving Use of Medication Inhalers: Factors Linked to Suboptimal Inhaler Use

Oral Presentations: 2:15 Effects of an Interdisciplinary Clinical Care Pathway on Mortality With Patients Admitted for Pneumonia 2:27 Prognostic and Pathogenic Role of Angiopoietin-like 4 (ANGPTL-4) in Severe Community Acquired Pneumonia 2:39 Descriptive Analysis of ICU Outcomes in Severe Pneumonia: A Comparative Study Between COVID-19 and Other Pathogens With an Emphasis on Phenotypic Variability 2:51 Sectm1a Suppresses IL-17a Production of Gamma-delta T Cells and Influences Bacterial Clearance During Pneumococcal Pneumonia 3:03 Lung Mesenchymal Stem Cells Attenuate Chronic Secondhand Smoke-induced Alveolar Destruction and Protect Against Streptococcus Pneumoniae 3:15 Beta-lactam Plus Macrolides Treatment Vs Beta-lactam Monotherapy in Community Acquired Pneumonia: A Propensity Score Analysis Using a Data From Japanese Multicenter Registry

ATS 2024 Conference Program • San Diego, CA